The page is the record's research on the issuer — no analyst, no rating, no view.

Kalaris Therapeutics, Inc. (KLRS) — research page

US · us-cm-kg/NASDAQ/KLRS · as of 2026-11-08

Identity and listing

Kalaris Therapeutics, Inc. is listed on NASDAQ under the ticker KLRS, with ISIN US4829291065. The LEI is not on the record, because no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.

fieldvaluesource · read date
nameKalaris Therapeutics, Inc.source · 2026-11-08
exchangeNASDAQsource · 2026-11-08
tickerKLRSsource · 2026-11-08
ISINUS4829291065source · 2026-09-30
LEInot on the record
security typeCorporatesource · 2026-11-08
segmentnot on the record
sector2836 Biological Products, (No Diagnostic Substances)source · 2026-11-08
jurisdictionUnited States — Delawaresource · 2026-11-08
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 56 filings across 26 filing days in the window 2025-11-08 to 2026-11-08. By type, the record holds 20 directors_dealings, 14 regulatory_filing, 8 results, 4 corporate_news, 4 prospectus, 3 agm_egm and 3 director_change filings. The median gap between filing days is 8 days. The latest filing is a regulatory_filing dated 2026-10-26, 13 days before the record date of 2026-11-08. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days across 4359 issuers. The sector median is 65.5 filings, a median cadence gap of 5.5 days and a median latency of 4.0 days across 176 issuers.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer56813
exchange median: NASDAQ (4359 issuers)5265
sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers)65.55.54
datetypecategoryfiling
2026-10-26regulatory_filingSCHEDULE 13GSCHEDULE 13G
2026-08-28directors_dealings44 — 4
2026-08-11results10-Q10-Q — 10-Q
2026-08-11results8-K8-K — 8-K (items 2.02,9.01)
2026-08-03directors_dealings44 — 4

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change events. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

Open research

No openly published research notes were found on the record. The count is 0.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
10.2
https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
10.3
https://data.sec.gov/submissions/CIK0001754068.json (identity.jurisdiction)
10.4
https://mcp.us-cm-kg.ai/events/NASDAQ/KLRS (the disclosure lines)
10.5
https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
10.6
https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://mcp.us-cm-kg.ai/record/NASDAQ/KLRS (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US4829291065"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:16797719af904a7c.